Evidence map›Paper›PMID 27741117›Full record

ReviewMedicine2016

Radiation-induced heart disease in lung cancer radiotherapy: A dosimetric update.

Xin Ming, Yuanming Feng, Chengwen Yang, Wei Wang, Ping Wang, Jun Deng

Open access · goldAbstract readReview
In one paragraph

Review in Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Deep learning-based automatic segmentation of cardiac substructures for lung cancers.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2024
    Article
  9. Article
  10. External validation ofClinical and translational radiation oncology · 2023
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Percutaneous Image-Guided Ablation of Lung Tumors.Journal of clinical medicine · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Xin MingDepartment of Biomedical Engineering, Tianjin University Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China Department of Therapeutic Radiology, Yale University, New Haven, CT, USA.
Yuanming Feng
Chengwen Yang
Wei Wang
Ping Wang
Jun Deng
Tianjin University · CNTianjin Medical University Cancer Institute and Hospital · CNYale University · US

Funding

Tracking Organ Doses for Patient Safety in Radiation TherapyR01EB022589 · NIBIB · YALE UNIVERSITY · PI DENG, JUN · 2016 to 2018
$1.1M
NIBIB NIH HHS R01 EB022589
6 · The paper itself

Abstract

backgroundRadiation-induced heart disease (RIHD), which affects the patients' prognosis with both acute and late side effects, has been published extensively in the radiotherapy of breast cancer, lymphoma and other benign diseases. Studies on RIHD in lung cancer radiotherapy, however, are less extensive and clear even though the patients with lung cancer are delivered with higher doses to the heart during radiation treatment.

methodsIn this article, after extensive literature search and analysis, we reviewed the current evidence on RIHD in lung cancer patients after their radiation treatments and investigated the potential risk factors for RIHD as compared to other types of cancers.

resultCardiac toxicity has been found highly relevant in lung cancer radiotherapy. So far, the crude incidence of cardiac complications in the lung cancer patients after radiotherapy has been up to 33%.

conclusionThe dose to the heart, the lobar location of tumor, the treatment modality, the history of heart and pulmonary disease and smoking were considered as potential risk factors for RIHD in lung cancer radiotherapy. As treatment techniques improve over the time with better prognosis for lung cancer survivors, an improved prediction model can be established to further reduce the cardiac toxicity in lung cancer radiotherapy.

Indexed as

Radiation InjuriesGlobal HealthHumansIncidenceLung NeoplasmsRadiotherapy DosageRisk Factors

Identifiers

PMID27741117
PMCPMC5072944
OpenAlexW2530717372

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.